Thomas SM - Search Results

1

The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.

Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H, Tazi L, Manna P, Kerley S, Joshi R, Wang L, Chiosea SI, Garnett JD, Tsue TT, Chien J, Mills GB, Grandis JR, Thomas SM. Ledgerwood LG, et al. Among authors: thomas sm. Oncotarget. 2016 May 10;7(19):27185-98. doi: 10.18632/oncotarget.8448. Oncotarget. 2016. PMID: 27034009 Free PMC article.

2

Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy.

Thomas SM, Zeng Q, Dyer KF, Suscovich TJ, Kanter PM, Whalen JD, Watkins SF, Grandis JR. Thomas SM, et al. Cancer Gene Ther. 2003 Jul;10(7):518-28. doi: 10.1038/sj.cgt.7700567. Cancer Gene Ther. 2003. PMID: 12833132

3

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.

Lui VW, Thomas SM, Zhang Q, Wentzel AL, Siegfried JM, Li JY, Grandis JR. Lui VW, et al. Among authors: thomas sm. Oncogene. 2003 Sep 18;22(40):6183-93. doi: 10.1038/sj.onc.1206720. Oncogene. 2003. PMID: 13679857

4

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR. Thomas SM, et al. Cancer Res. 2003 Sep 1;63(17):5629-35. Cancer Res. 2003. PMID: 14500405

5

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

Thomas SM, Grandis JR. Thomas SM, et al. Cancer Treat Rev. 2004 May;30(3):255-68. doi: 10.1016/j.ctrv.2003.10.003. Cancer Treat Rev. 2004. PMID: 15059649 Review.

6

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.

Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Grandis JR. Zhang Q, et al. Among authors: thomas sm. Cancer Res. 2004 Sep 1;64(17):6166-73. doi: 10.1158/0008-5472.CAN-04-0504. Cancer Res. 2004. PMID: 15342401

7

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.

Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR. Thomas SM, et al. Clin Cancer Res. 2004 Oct 15;10(20):7079-87. doi: 10.1158/1078-0432.CCR-04-0587. Clin Cancer Res. 2004. PMID: 15501988

8

Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.

Thomas SM, Grandis JR, Wentzel AL, Gooding WE, Lui VW, Siegfried JM. Thomas SM, et al. Neoplasia. 2005 Apr;7(4):426-31. doi: 10.1593/neo.04454. Neoplasia. 2005. PMID: 15967120 Free PMC article.

9

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG, Ferris RL. Wang J, et al. Among authors: thomas sm. Oncogene. 2005 Sep 1;24(38):5897-904. doi: 10.1038/sj.onc.1208740. Oncogene. 2005. PMID: 16007209

10

Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

Zhang Q, Thomas SM, Lui VW, Xi S, Siegfried JM, Fan H, Smithgall TE, Mills GB, Grandis JR. Zhang Q, et al. Among authors: thomas sm. Proc Natl Acad Sci U S A. 2006 May 2;103(18):6901-6. doi: 10.1073/pnas.0509719103. Epub 2006 Apr 25. Proc Natl Acad Sci U S A. 2006. PMID: 16641105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

702 results

Search Page